Cedars-Sinai First To Purchase Gauss Surgical’s Triton System™ For Real-Time Assessment of Surgical Blood Loss
Cedars-Sinai Will Also Work With Gauss to Study the Technology’s Role in Clinical Decision Making and Patient Outcomes
Los Altos, Calif., Nov.11, 2014 – Gauss Surgical today announced that Cedars-Sinai Medical Center in Los Angeles, the largest academic medical center in the western United States, is the first institution to purchase the Triton Fluid Management System™. Triton is the world’s first and only mobile platform for real-time assessment of blood loss on surgical sponges. In addition, Cedars-Sinai will partner with Gauss Surgical to further explore the role of the technology in improving patient outcomes and reducing unnecessary blood transfusions and their associated costs and complications.
“We believe Triton will contribute to the quality of care for which Cedars-Sinai is known by helping us to better assess intraoperative blood loss,” said Bruce Gewertz, M.D., Cedars-Sinai’s surgeon-in-chief and chairman of the Department of Surgery. “In addition to its immediate impact on patient outcomes, we look forward to studying its role in clinical decision making, including utilization of blood products, and other quality- and value- related metrics.”
Triton provides physicians a first of its kind device to accurately estimate blood loss during surgery. At its core Triton uses standard off the shelf mobile computing technology in combination with cloud storage. Using the iPad camera, the system scans surgical sponges that are covered in blood, and sends the images to the cloud where image-processing algorithms estimate the amount of blood contained on that surface and sends it back to the OR in real-time. Triton features an intuitive iPad interface, requires minimal training, and seamlessly integrates into existing surgical workflow. The system is fully HIPAA compliant.
“Cedars-Sinai is a world renowned medical institution with a reputation for innovation, quality care and clinical excellence,” said Milton B. McColl, M.D., Chief Executive Officer of Gauss Surgical. “We are proud to have them as our first customer and look forward to working collaboratively to further enhance our product, and further evaluate its impact in advancing surgical science.”
The Triton Fluid Management system received U.S. Food and Drug Administration (FDA) clearance via granting of a de novo petition in May of 2014 and is now commercially available.
About Gauss Surgical
Founded in 2011 and headquartered in Los Altos, Calif. Gauss is developing a mobile platform for accurate, real-time monitoring of surgical blood loss. The system uses sophisticated cloud-based computer vision algorithms to estimate blood loss. This first-of-kind system gives operating room personnel the means to estimate blood loss on sponges in real time. For more information, go to http://www.gausssurgical.com.